Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $641.14 thousand versus the consensus estimate of $375 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.